Verrica Pharmaceuticals Inc. (VRCA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -9.16M | -4.59M | 9.69M | -10.04M | -12.68M | -16.06M | -8.56M | -16.36M | -19.95M | -14.51M | -14.81M | -4.67M | -4.59M | -4.95M | 1.82M | -7.18M | -8.34M | -8.7M | -10.6M | 2.5M |
| Operating CF Margin % | -182.42% | -90.16% | 67.52% | -79.07% | -368.62% | -4669.77% | 480.52% | -315.97% | -521.35% | -729.73% | -507.75% | -2565.38% | -12405.41% | -7285.29% | 21.94% | -3355.61% | -1935.03% | - | - | - |
| Operating CF Growth % | 27.72% | 71.42% | 213.17% | 38.6% | 36.45% | -10.73% | 42.22% | -250.35% | -334.58% | -192.83% | -911.56% | 34.98% | 44.96% | 43.04% | 117.22% | -387.35% | 22.67% | -42.61% | -39.3% | 129.08% |
| Net Income | -9.68M | -8.07M | -274K | 204K | -9.74M | -16.2M | -22.86M | -17.19M | -20.33M | -24.61M | -24.8M | -10.99M | -6.59M | -5.93M | 83K | -10.17M | -8.47M | -9.54M | -12.83M | -11.78M |
| Depreciation & Amortization | 194K | 174K | 184K | 118K | 208K | 253K | 342K | 334K | 340K | 217K | 210K | 207K | 202K | 395K | 321K | 98K | 98K | 370K | 54K | 37K |
| Stock-Based Compensation | 0 | 686K | 718K | 888K | 1.03M | 756K | 2.11M | 2.23M | 2.07M | 2.08M | 9.66M | 1.54M | 1.09M | 1.17M | 1.41M | 1.08M | 1.32M | 1.32M | 1.48M | 1.85M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -118K | 0 | 0 |
| Other Non-Cash Items | 2.35M | 615K | 1.12M | 353K | 417K | 3.22M | 832K | 657K | 483K | 2.95M | 399K | 0 | 0 | -172K | 1.08M | 418K | 409K | 361K | 448K | 382K |
| Working Capital Changes | -2.02M | 2.01M | 7.93M | -11.61M | -4.59M | -4.09M | 11.02M | -2.39M | -2.51M | 4.87M | -281K | 4.57M | 703K | -416K | -1.08M | 1.39M | -1.69M | -1.09M | 248K | 12.01M |
| Change in Receivables | -2.42M | 1.93M | 10.04M | -11.72M | -5.56M | -146K | 10.28M | -2.62M | -3.18M | -344K | -3.9M | -117K | 431K | -68K | -201K | 213K | -431K | 0 | 0 | 11.5M |
| Change in Inventory | 262K | 0 | 218K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68K | 0 | -213K | 0 | 0 | 0 | 0 |
| Change in Payables | 121K | 487K | -736K | 878K | -453K | 931K | -169K | -1.38M | 52K | 578K | 121K | 1.49M | 14K | 370K | -577K | 183K | -314K | -25K | 87K | -90K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 8K | -16K | -11K | 0 | -227K | -65K | -59K | -11K | 6.75M | 2.07M | 2.21M | 43.01M | 4.01M | 6.29M | -22.14M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | -16K | -11K | 0 | -227K | -65K | -59K | -11K | -66K | -77K | -154K | -5K | -237K | -39K | -296K |
| CapEx % of Revenue | - | - | - | - | - | - | -0.9% | 0.21% | - | 11.42% | 2.23% | 32.42% | 29.73% | 97.06% | 0.93% | 71.96% | 1.16% | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 8K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -180K | 146K | -141K | 0 | -124K | 0 | -8K |
| Cash from Financing | -120K | 13.64M | -3.98M | -4.16M | -4.06M | 39.43M | -397K | -640K | -661K | -27K | 44.04M | -84K | 30.28M | -87.5M | -16.85M | -1K | -18K | -3K | 43K | 241K |
| Debt Issued (Net) | -111K | -36.01M | -3.98M | -4.16M | -4.06M | -1.51M | -234K | -177K | -665K | -23K | 44.1M | 0 | 0 | -43.75M | -43.75M | -1K | -1K | -2K | -2K | -1K |
| Equity Issued (Net) | -9K | 50.07M | 0 | 0 | 0 | 39.64M | -163K | 150K | 4K | -1K | -61K | -84K | 30.3M | 0 | 26.9M | 0 | 0 | -1K | 0 | -31K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -420K | 0 | 0 | 0 | 1.3M | 0 | -613K | 0 | -3K | 0 | 0 | -21K | 43.75M | 0 | 0 | -17K | 0 | 45K | 273K |
| Net Change in Cash | -9.55M | 9.05M | 5.7M | -14.2M | -16.73M | 23.37M | -8.97M | -17.01M | -20.61M | -14.76M | 29.17M | -4.81M | 25.68M | 1.8M | -12.96M | -4.98M | 34.66M | -4.69M | -4.26M | -19.39M |
| Free Cash Flow | -9.16M | -4.59M | 9.69M | -10.04M | -12.68M | -16.06M | -8.57M | -16.37M | -19.95M | -14.73M | -14.88M | -4.73M | -4.6M | -5.02M | 1.75M | -7.33M | -8.35M | -8.94M | -10.64M | 2.2M |
| FCF Margin % | -182.42% | -90.16% | 67.52% | -79.07% | -368.62% | -4669.77% | 481.41% | -316.19% | -521.35% | -741.15% | -509.98% | -2597.8% | -12435.14% | -7382.35% | 21.01% | -3427.57% | -1936.19% | - | - | - |
| FCF Growth % | 27.72% | 71.42% | 212.96% | 38.64% | 36.45% | -9.03% | 42.36% | -246.21% | -333.54% | -193.51% | -951.03% | 35.54% | 44.87% | 43.82% | 116.43% | -432.96% | 24.79% | -34.5% | -37.8% | 125.29% |
| FCF per Share | -0.86 | -0.43 | 1.02 | -1.06 | -1.34 | -2.39 | -1.83 | -3.52 | -4.29 | -3.18 | -3.23 | -1.03 | -1.07 | -1.22 | 0.39 | -2.67 | -3.03 | -3.25 | -3.87 | 0.80 |
| FCF Conversion (FCF/Net Income) | 0.95x | 0.57x | -35.35x | -49.24x | 1.30x | 0.99x | 0.37x | 0.95x | 0.98x | 0.59x | 0.60x | 0.42x | 0.70x | 0.84x | 21.99x | 0.71x | 0.98x | 0.91x | 0.83x | -0.21x |
| Interest Paid | 0 | 0 | 1.38M | 0 | 0 | 1.73M | 0 | 0 | 0 | 1.83M | 0 | 0 | 0 | 0 | 320K | 0 | 725K | 0 | 741K | 742K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |